Skip to nav Skip to content

242 Stories Found

Precision Surgery and Its Role in Genitourinary Cancer Therapy

At Moffitt, we specialize in advanced surgical procedures such as MIS to complex reconstructive surgeries.

Dr. Yu receives an award at ASTRO

Moffitt Physicians Honored at ASTRO 2024

Drs. Anupam Rishi and Michael Yu were recognized at the 2024 Annual Meeting of the American Society for Radiation Oncology (ASTRO).

lung cancer cells

Breakthrough Treatment for Small Cell Lung Cancer: New Therapy Offers Hope for Advanced-Stage Patients

Moffitt is proud to be the first institution in the United States to offer tarlatamab as a standard treatment for patients with extensive-stage SCLC.

Targeted Triumph: Precision Surgery for Breast Cancer

The SmartClip® technology for breast cancer surgery represents a significant advancement in our surgeons' ability to precisely localize and remove...

Diverse men and women

Improving Cancer Care for All: The Case for Representation in Clinical Trials

A critical disparity persists in cancer care: racial and ethnic minorities remain significantly underrepresented in clinical trials despite often...

graphic image of skin cells emerging to the top of the skin as cancerous melanoma

Revolutionizing Treatment for Node-Positive Melanoma: Neoadjuvant Therapy

Neoadjuvant therapy is advancing the fight against this aggressive form of skin cancer, creating a new standard of care. 

Dr. Hye Sook Chon in the operating room

SCOUTMD® Radar Localization: Revolutionizing Breast Cancer Surgery

The Breast Oncology Program at Moffitt Cancer Center is proud to be the first cancer center in the U.S. to offer SCOUTMD® Radar Localization.

Moffitt surgeons in the operating room

Oncoplastic Surgery: Advancement in Breast Cancer Surgery

As a referring provider, it's crucial to understand that oncoplastic surgery is now an integral component of all breast cancer surgeries

Comprehensive Care for Endocrine Tumors at Moffitt

The Endocrine Oncology Program offers specialized care for both malignant and benign endocrine tumors using advanced techniques for complex cases.

Advancing Endometrial Cancer Treatment with Targeted Therapies

In June, the FDA approved the use of Durvalumab with carboplatin plus paclitaxel followed by single-agent durvalumab for patients with primary...

liver shown isolated for PHP treatment

FDA Approval of Percutaneous Hepatic Perfusion Offers Patients New Hope

The FDA recently approved Percutaneous Hepatic Perfusion (PHP) with the HEPZATO KIT to treat metastatic uveal melanoma.

synovial sarcoma cells

FDA Approves New Gene Therapy for Synovial Sarcoma

The FDA granted accelerated approval for Tecelra (afamitresgene autoleucel), a groundbreaking gene therapy for metastatic synovial sarcoma.

Q&A: Insights on Oral Cavity Cancer Treatment

Due to their aggressive nature, it's crucial to have treatment by an experienced surgeon and a multidisciplinary team from the first diagnosis of...

Dr. James Liu in the Neuro-Oncology Program

Minimally Invasive Surgery Advancements for Spinal Tumor Surgery

The Minimally Invasive Spine Oncology (MISO) program is patient-centered with a focus on the use of minimal access techniques for the treatment of...

Dr. Fredrick Locke in the research lab

Recent FDA Approvals for New Uses of Cellular Therapies

Recent advancements in cellular therapies, such as CAR T and TILs, have led to new FDA approvals for expanded uses.